--- title: "Diploma (LON:DPLM) Reaches New 52-Week High - Should You Buy?" type: "News" locale: "en" url: "https://longbridge.com/en/news/283632529.md" description: "Diploma PLC (LON:DPLM) reached a new 52-week high of GBX 6,965 during trading, closing at GBX 6,960. Analysts have raised their target prices, with Berenberg Bank setting a new target of GBX 7,500 and maintaining a \"buy\" rating. Overall, five analysts rate the stock as a \"buy\" and three as \"hold,\" with an average target price of GBX 6,251.25. The company has a market cap of £9.29 billion and operates in specialized technical products and services across various sectors." datetime: "2026-04-22T09:21:12.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/283632529.md) - [en](https://longbridge.com/en/news/283632529.md) - [zh-HK](https://longbridge.com/zh-HK/news/283632529.md) --- # Diploma (LON:DPLM) Reaches New 52-Week High - Should You Buy? Shares of Diploma PLC (LON:DPLM - Get Free Report) reached a new 52-week high during mid-day trading on Wednesday . The company traded as high as GBX 6,965 and last traded at GBX 6,960, with a volume of 578314 shares. The stock had previously closed at GBX 6,917.29. ## Analysts Set New Price Targets Several equities analysts recently weighed in on the company. Berenberg Bank lifted their target price on Diploma from GBX 6,600 to GBX 7,500 and gave the company a "buy" rating in a research report on Thursday, March 19th. Stifel Nicolaus lifted their target price on Diploma from GBX 6,200 to GBX 6,800 and gave the stock a "buy" rating in a report on Thursday, March 19th. JPMorgan Chase & Co. boosted their price objective on Diploma from GBX 5,120 to GBX 5,760 and gave the stock a "neutral" rating in a research note on Friday, March 27th. Jefferies Financial Group boosted their price objective on Diploma from GBX 5,200 to GBX 5,700 and gave the stock a "hold" rating in a research note on Monday, March 23rd. Finally, Royal Bank Of Canada upped their target price on Diploma from GBX 6,200 to GBX 6,600 and gave the company an "outperform" rating in a research note on Thursday, March 19th. Five equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of GBX 6,251.25. **Read Our Latest Stock Analysis on Diploma** ## Diploma Stock Performance The business has a fifty day simple moving average of GBX 5,836.31 and a two-hundred day simple moving average of GBX 5,572.35. The company has a debt-to-equity ratio of 46.97, a current ratio of 2.04 and a quick ratio of 0.80. The company has a market cap of £9.29 billion, a PE ratio of 50.47, a price-to-earnings-growth ratio of 2.82 and a beta of 0.89. ## Insiders Place Their Bets In related news, insider Ian El-Mokadem bought 500 shares of the stock in a transaction on Friday, March 20th. The stock was bought at an average price of GBX 5,820 per share, for a total transaction of £29,100. 1.14% of the stock is currently owned by corporate insiders. ## About Diploma (Get Free Report) Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products. ## Featured Articles - Five stocks we like better than Diploma _This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com._ ## Should You Invest $1,000 in Diploma Right Now? Before you consider Diploma, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diploma wasn't on the list. While Diploma currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [DPLM.UK](https://longbridge.com/en/quote/DPLM.UK.md) - [SF.US](https://longbridge.com/en/quote/SF.US.md) - [JPM.US](https://longbridge.com/en/quote/JPM.US.md) - [JEF.US](https://longbridge.com/en/quote/JEF.US.md) - [RY.US](https://longbridge.com/en/quote/RY.US.md) - [SF-C.US](https://longbridge.com/en/quote/SF-C.US.md) - [SFB.US](https://longbridge.com/en/quote/SFB.US.md) - [SF-B.US](https://longbridge.com/en/quote/SF-B.US.md) - [SF-D.US](https://longbridge.com/en/quote/SF-D.US.md) - [JPM-M.US](https://longbridge.com/en/quote/JPM-M.US.md) - [JPM-C.US](https://longbridge.com/en/quote/JPM-C.US.md) - [JPM-D.US](https://longbridge.com/en/quote/JPM-D.US.md) - [JPM-L.US](https://longbridge.com/en/quote/JPM-L.US.md) - [8634.JP](https://longbridge.com/en/quote/8634.JP.md) - [JPM-K.US](https://longbridge.com/en/quote/JPM-K.US.md) - [JPM-J.US](https://longbridge.com/en/quote/JPM-J.US.md) ## Related News & Research - [Diploma (LON:DPLM) Sets New 1-Year High - Time to Buy?](https://longbridge.com/en/news/272536762.md) - [Shore Capital Sticks to Their Hold Rating for Diploma (DPLM)](https://longbridge.com/en/news/279719078.md) - [16:52 ETNexusTek Named a Contender in ISG Provider Lens® Life Sciences Digital Services 2026 Report](https://longbridge.com/en/news/286818120.md) - [What Are Wall Street Analysts' Target Price for Leidos Holdings Stock?](https://longbridge.com/en/news/287067406.md) - [Wave Life Sciences Supports AlphaDetect to Accelerate Detection of Alpha-1 | WVE Stock News](https://longbridge.com/en/news/286925108.md)